Zai Lab
ZLAB
$16.25
Share price
-2.05%
Change (1 day)
-56.84%
Change (1 year)
Categories
P/S ratio for Zai Lab (ZLAB)
P/S ratio as of May 2024 (TTM): 6.36
According to Zai Lab's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.36227. At the end of 2023 the company had a P/S ratio of 10.1.
P/S ratio history for Zai Lab from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.1 | -30.76% |
| 2022 | 14.6 | -66.26% |
| 2021 | 43.3 | -81.9% |
| 2020 | 239 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | -83.51% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 1,353.86% | 🇺🇸 USA |